MedPath

Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
Behavioral: Neurofeedback training
Behavioral: Computerized cognitive training
Registration Number
NCT02358941
Lead Sponsor
University of Zurich
Brief Summary

Attention deficit/hyperactivity disorder (ADHD) is among the most common childhood-onset psychiatric disorders, with a negative and long-lasting impact on academic achievement, social integration and quality of life. In recent years, the efficacy of non-pharmacological treatments for ADHD, such as neurofeedback training (NF) and computerized cognitive training (CCT), has been at the centre of research. Although an increasing number of well-designed studies have shown that both methods may improve ADHD core symptoms according to parents' ratings, the underlying mechanisms are still a matter of debate. Teachers often report smaller improvements, if any. This has been explained by their lesser involvement in the training. It remains questionable, however, whether other factors may also account for this effect and whether methods other than placebo control may be applied in order to demonstrate the specificity and efficacy of NF and CCT.

The main purpose of this project is to demonstrate and compare the efficacy of two different computer-based treatment methods for children and adolescents with ADHD, namely NF and CCT, and to examine the impact of different treatment settings, with half of the participants being trained in a clinical setting and the other half at school. The investigators want to show that is feasible to implement NF and CCT in a school setting and that both methods, conducted either at school or in a clinical setting, may lead to significant improvements of ADHD symptoms as well as to specific and differential effects. Besides the differential impact of the settings on informant ratings, the investigators will evaluate the effects of the training methods on neuropsychological and electrophysiological outcome. Classroom behavior of the children before and after the training will be evaluated by trained observers not informed on treatment assignments and settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
102
Inclusion Criteria
  • ADHD (DSM IV)
Read More
Exclusion Criteria
  • Estimated IQ < 80
  • Known neurological impairment / brain injury
  • Severe comorbid conditions (e.g. CD, ODD, autism)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Training in a clinical settingComputerized cognitive trainingA minimum of 30 sessions (45 min.) over approx. 12 weeks at the Department of Child and Adolescent Psychiatry (treatment as usual). Half of the children will be assigned to NF training, the other half to CCT.
Training in a school settingNeurofeedback trainingA minimum of 30 sessions (45 min.) over at least 12 weeks in the schools of the participants. Half of the children will be assigned to NF training, the other half to CCT.
Training in a school settingComputerized cognitive trainingA minimum of 30 sessions (45 min.) over at least 12 weeks in the schools of the participants. Half of the children will be assigned to NF training, the other half to CCT.
Training in a clinical settingNeurofeedback trainingA minimum of 30 sessions (45 min.) over approx. 12 weeks at the Department of Child and Adolescent Psychiatry (treatment as usual). Half of the children will be assigned to NF training, the other half to CCT.
Primary Outcome Measures
NameTimeMethod
ADHD behavioral symptomsOutcome assessment 6 months after baseline

Primary outcome measures will be assessed by clinical scales (Conners 3), rated by parents and teachers.

Secondary Outcome Measures
NameTimeMethod
Neuropsychological performance, EEG parametersOutcome assessment 6 months after baseline

Computerized test battery for attention and working memory; Q-EEG, event related potentials

Trial Locations

Locations (1)

University Clinic of Child and Adolescent Psychiatry, University of Zürich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath